
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : ONA-255
Therapeutic Area : Oncology
Study Phase : IND Enabling
Recipient : Ona Therapeutics
Deal Size : Undisclosed
Deal Type : Collaboration
Reveal Genomics and Ona Therapeutics Partner to Advance Cancer Treatments
Details : The collaboration aims to accelerate the clinical development of ONA-255, a next-generation antibody-drug conjugate (ADC) designed to enhance the precision and effectiveness of cancer treatment.
Product Name : Undisclosed
Product Type : Antibody-drug Conjugate
Upfront Cash : Undisclosed
April 14, 2025
Lead Product(s) : ONA-255
Therapeutic Area : Oncology
Highest Development Status : IND Enabling
Recipient : Ona Therapeutics
Deal Size : Undisclosed
Deal Type : Collaboration
